智通财经APP讯，圣湘生物(688289.SH)发布公告，公司的产品全自动核酸处理系统(S-S13E-P/S-S13E-P1)于近日获得欧盟CEIVDR认证。该设备可实现从样本到报告的全流程自动化，包括样本管开盖、移液、核酸提取、PCR体系构建、封膜扩增及结果分析，具有处理高效、检测精准、智能控制、广泛兼容等特点。检测项目丰富，涵盖HPV、性病、血源、呼吸道、虫媒、药物基因组等类别，适配实验室、医院、检验中心等各类专业应用场景，在有限空间内高效满足样本检测、实验分析等多元化需求。
该款仪器本次获得欧盟CEIVDR认证，标志着公司在分子诊断技术国际化与标准化进程迈出关键一步。这一里程碑不仅体现了产品的卓越性能与安全标准，更展现了公司引领行业创新、服务全球市场的坚定承诺。未来，公司将持续推动技术革新与方案融合，赋能全球医疗机构与公共卫生体系，助力构建更高效、精准、可靠的健康防控新生态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.